Thousands of tins of infant formula have been recalled by a2 Milk Company over the possible presence of cereulide, a toxin that can cause illness in infants, according to a notice from the U.S. Food and Drug Administration posted Saturday.
The FDA announced that three batches of a2 Platinum Premium USA formula, marketed for children 12 months old and younger, were voluntarily recalled after testing revealed the presence of cereulide, a toxin produced by some strains of Bacillus cereus bacteria. The affected product was sold in 31.7-ounce tins through the company's website, Amazon, and Meijer stores.
The recall impacts three lots with batch numbers 2210269454 (use-by date 7/15/2026), 2210324609 (use-by date 1/21/2027), and 2210321712 (use-by date 1/15/2027). The affected tins can be identified by checking the bottom of the container. Of more than 63,000 tins produced, approximately 16,400 are believed to have been sold to consumers.
The toxin was discovered during testing conducted in response to new guidance from authorities in New Zealand. According to the FDA notice, cereulide is not eliminated even when formula is prepared with hot water and can cause illness within as little as 30 minutes of consumption.
What the Right Is Saying
Republican lawmakers and free-market advocates have highlighted that the recall was issued voluntarily by the company following testing protocols, suggesting that market mechanisms and corporate responsibility can work alongside regulatory frameworks. Senator Ron Johnson of Wisconsin noted that rapid identification and voluntary action by a2 Milk Company demonstrates how existing safety systems functioned as intended.
Conservative commentators have argued against expanding FDA authority over imported products, contending that such measures could restrict supply options for families already facing limited choices in the infant formula market. The American Enterprise Institute has written that prescriptive rules on foreign production could disproportionately burden smaller international manufacturers and reduce competition.
What the Left Is Saying
Democratic lawmakers and consumer advocacy groups have emphasized that the recall demonstrates the importance of federal regulatory oversight in protecting infant health. Senator Patty Murray of Washington state, who has previously advocated for stronger FDA authority over baby food safety, said the recall underscores the need for continued vigilance as families rely on commercially produced formula.
The Environmental Working Group and other progressive health advocates pointed to Operation Fly Formula, an initiative launched during the previous administration to address a nationwide shortage, arguing that expanded importation of infant formula increases the complexity of supply chain oversight. These groups have called for additional funding for FDA inspection capabilities at international production facilities.
What the Numbers Show
According to the FDA notice: approximately 16,400 tins were sold to consumers out of more than 63,000 produced across three batches. No confirmed reports of infant illness linked to the recalled formula have been documented as of Saturday. The affected product includes batch numbers 2210269454, 2210324609, and 2210321712 with use-by dates ranging from July 2026 through January 2027.
The imported formula was part of Operation Fly Formula shipments that entered the U.S. market to address a national shortage triggered by safety concerns at Abbott's Michigan manufacturing facility in 2022. Importation rights for this product ended in December, though consumers may still possess affected tins.
Cereulide symptoms typically develop within six hours and are generally gastrointestinal, including nausea and vomiting. While these effects usually resolve within a day, the FDA warns that infants face greater risk of complications such as dehydration requiring medical care.
The Bottom Line
The recall highlights ongoing questions about oversight of imported infant formula even as Operation Fly Formula shipments have concluded. Parents who purchased a2 Platinum Premium formula should check batch numbers on their tins and either discard the product or return it to the point of purchase for a full refund.
Consumers with questions can find contact information for a2 Milk Company through the FDA's recall notice. The agency advises parents whose infants experience illness after consuming the formula to contact their health care provider. The FDA reported last month that recent testing indicates the broader infant formula supply remains largely free from contaminants, though this recall demonstrates continued need for monitoring of specific products already in circulation.